Financing in the Time of COVID

Complimentary Live Stream
Recorded March 3, 2021

Program director Gil Kliman MD, Managing Partner at InterWest Partners, along with co-moderators Andrew Gitkin, Managing Director, Co-Head of Health Care Investment Banking at Raymond James, and Eric Donnenfeld MD, Clinical Professor of Ophthalmology, NYU, led discussions centered around unexpected investment opportunities that have emerged during the pandemic.


Gil Kliman, MD

A Gitkin.jpg

Andrew Gitkin

E Donnenfeld.jpg

Eric Donnenfeld, MD

The 90-minute program provided an inside look at how high-growth public companies, global strategics, and some of ophthalmology's most active and seasoned investors are moving innovation forward with new financing tools... and new thinking.



8:00 – 8:05 a.m.

Gil Kliman, MD (InterWest Partners)

Pandemic Public Markets: Black Swans and Bulls

8:05 – 8:10 a.m.

Andrew Gitkin (Raymond James)

Public Financing Strategies During the 2020 Pandemic

8:10 – 8:40 a.m.

This wide-ranging discussion about raising capital will touch on traditional financing, IPO, and even use of the new "special purpose acquisition company (SPAC)" as an avenue for moving innovation forward through COVID-19.

Moderator: Andrew Gitkin (Raymond James)

Panelists: Joe Gilliam, CFO & SVP, Corporate Strategy & Development (Glaukos); Leo Greenstein, CFO (Tarsus Pharmaceuticals); Brian Piekos, CFO (Gemini Therapeutics)

Private Financing and Strategic Partnering in 2021

8:40 – 9:26 a.m.

Get an inside look into how global strategics and seasoned investors are engaging with innovation companies during the pandemic. Is COVID speeding up deals? Is the bullish public market affecting private investment?

8:40 – 9:03 a.m. 

Panel 1: Private Financing

Moderator: Gil Kliman, MD
Panelists: Wende Hutton, General Partner (Canaan Partners); Bill Link, PhD, Managing Partner (Flying L); Bruce Robertson, Managing Director (HIG Capital); Nick Pliam, MD, PhD, Partner (Decheng Capital)

9:03 – 9:26 a.m. 

Panel 2: Strategic Partnering

Moderator: Eric Donnenfeld, MD

Panelists: Laurent Attias, Senior Vice President of Corporate Development Strategy, BD&L and M&A (Alcon); Jag Dosanjh, Senior Vice President, Specialty Therapeutics (Allergan, An AbbVie Company);  Warren Foust, Worldwide President, Surgical Vision (Johnson & Johnson Vision); Chuck Hess, VP & General Manager, US Surgical (Bausch Health); Euan Thomson, PhD, President Ophthalmic Devices and Head of Digital Business Unit (Zeiss)

Closing Remarks

9:26  – 9:30 a.m.

Thanks for attending!